Abstract-Movement of free cholesterol between the cellular compartment and acceptor is governed by cholesterol gradients that are determined by several enzymes and reverse cholesterol transport proteins. We have previously demonstrated that adenosine A 2A receptors inhibit foam cell formation and stimulate production of cholesterol 27-hydroxylase (CYP27A1), an enzyme involved in the conversion of cholesterol to oxysterols. We therefore asked whether the effect of adenosine A 2A receptors on foam cell formation in vitro is mediated by CYP27A1 or apoE, a carrier for cholesterol in the serum. We found that specific lentiviral siRNA infection markedly reduced apoE or 27-hydroxylase mRNA in THP-1 cells. Despite diminished apoE expression (p<0.0002, interferongamma (IFNγ) CGS vs. IFNγ alone, n=4), CGS-21680, an adenosine A 2A receptor agonist, inhibits foam cell formation. In contrast, CGS-21680 had no effect on reducing foam cell formation in CYP27A1 KD cells (4±2%; p<0.5113, inhibition vs. IFNγ alone, n=4). Previously, we reported the A 2A agonist CGS-21680 increases apoAI-mediated cholesterol efflux nearly twofold in wild-type macrophages. Adenosine receptor activation had no effect on cholesterol efflux in CYP27A1 KD cells but reduced efflux in apoE KD cells. These results demonstrate that adenosine A 2A receptor occupancy diminishes foam cell formation by increasing expression and function of CYP27A1.
INTRODUCTION
Previously, we have reported that adenosine A 2A receptor activation stimulates enhanced ATP binding cassette transporter A1 (ABCA1)-dependent cholesterol efflux but not ATP binding cassette transporter G1 (ABCG1)-dependent cholesterol efflux from human macrophages [1] [2] [3] [4] [5] . Cholesterol efflux from these cells contributes, in vivo, to reverse cholesterol transport from the periphery to the liver for elimination in the bile. However, in addition to the cholesterol transporters ABCA1 and ABCG1, there are several other proteins that contribute to reverse cholesterol transport, including apoprotein apoE and the enzyme cholesterol 27-hydroxylase (CYP27A1) [6] .
CYP27A1 contributes to enhanced cholesterol efflux from cells and leads to the transport of more soluble oxysterols to the liver for elimination [7] . In lipid-laden macrophages, cholesterol is converted by CYP27A1 to 27-hydroxycholesterol, which is more soluble in aqueous media [7] . The cytochrome P450 enzyme 27-hydroxylase has a number of roles in maintaining lipid homeostasis; however, its main role is to promote the formation of bile acids which help promote absorption of dietary lipids in the intestine and to stimulate the billiary excretion of cholesterol (Norlin and Wikvall [8] ). Point mutations in the human CYP27A1 gene are found in patients with the inherited lipid storage disease cerebrotendinous xanthomatosis, a syndrome characterized by accumulation of bile acids, accelerated atherosclerosis, osteoporosis, and neurologic impairment [8] .
The cholesterol transporter apoE mediates numerous effects, which result in protection from atherosclerosis. apoE promotes efficient uptake of triglyceride-rich lipoproteins from circulation, maintains normal macrophage lipid homeostasis, plays a role in cellular cholesterol efflux and reverse cholesterol transport, acts as an antioxidant, inhibits platelet aggregation, and modulates immune function [9] . apoE is produced in both hepatic cells and macrophages and is primarily involved in hepatic uptake of lipoprotein particles, stimulation of cholesterol efflux from macrophages, and regulation of immune and inflammatory responses [10] . In mice, disruption of the apoE gene results in spontaneous atherosclerosis. In apoE knockout mice, restoration of apoE prevents the atherosclerotic phenotype, providing further strong support for a direct role of this transporter in prevention of atherosclerosis. Also, apoE recycling requires the docking of high density lipoprotein (HDL)/apoA-I to receptors, such as ABCA1 and ABCG1, which then facilitates internalization of HDL/apoA-I [10] . The docking of HDL/apoA-I to the membrane promotes cholesterol translocation from the intracellular cholesterol pool to the cell membrane through the activation of phospholipases and protein kinase C [11, 12] . It has also been found that the nuclear hormone receptor LXR induces apoE expression in macrophages, and ABCA1 accelerated apoE secretion from macrophages [12] .
Because both CYP27A1 and apoE play such critical roles in reverse cholesterol transport and prevention of atherosclerosis, we determined whether activation of the adenosine A 2A receptor diminished foam cell formation and promoted reverse cholesterol transport via enhanced expression of these two proteins. We found that adenosine A 2A receptor stimulation inhibited foam cell formation by a mechanism dependent on the expression of CYP27A1.
MATERIALS AND METHODS

Infection of THP-1 Cells
THP-1 cells suspended in medium (1×10 6 /ml) are treated with hexadimethrine bromide from Sigma Chemical Co. (St. Louis, MO, USA; 8 μg/ml, final) and 10 8 transducing units of lentiviral particles corresponding to human apoE shRNA (SHVRS 08090813MN), human CYP27A (SHVRS 09300804MN), or scrambled shRNA (SHC002V 05210717MN) with a puromycin selection marker (Sigma Aldrich, St. Louis, MO, USA). Media is changed 24 h following infection and replaced with medium containing puromycin (1 μg/ml). After 7 days, cells are isolated and resuspended in medium; some cells were lysed and assayed for mRNA for apoE before and after treatment with interferon-gamma (IFNγ) in the presence or absence of the A 2A -selective agonist CGS-21680, the selective antagonist ZM-241385, or their combination (all at 1 μM final concentration).
Isolation of mRNA for Real-Time RT-PCR As we have previously described [1] , apoE KD cells or CYP27A1 KD cells (10 6 cells/ml) are treated with phorbol 12-myristate 13-acetate (PMA; 100 nM) for 48 h (37°C, 5% CO2) to differentiate into macrophages. Cells are washed with serum-free RPMI 1640 and further incubated with 50 μg/ml acetylated low density lipoprotein (LDL) for 3 h in the presence of IFNγ (500 U/ml) in the presence or absence of CGS21680 (1 μM), the A 2A antagonist ZM-241385 (1 μM), or their combination. Total RNA from cells is then extracted using Trizol (Invitrogen) according to the manufacturer's instructions, and 5 μg total RNA is used for first-strand, complementary cDNA synthesis primed with random hexamer primers using an RNA polymerase chain reaction (PCR) core kit (Invitrogen, Carlsbad, CA, USA).
Quantitative Real-Time PCR
For quantification of apoE message by real-time PCR, the following primer pairs are used: (apoE) 5′-aggatctacg caaccgactc-3′, 5′-ggcgatgcatgtcttccacta-3′, (CYP27A1) 5′-tgcgccaggctctgaaccag-3′, and 5′-tccacttggggaggaaggtg-3′. Human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression is used as an internal standard (5′-aacatcatccctgcctctac-3′ and 5′-ccctgttgctgtagccaaa-3′) under parallel conditions. PCR amplifications are detected using the SYBR Green kit from Applied Biosystems [1] . Cholesterol Efflux from THP-1 Cells apoE KD or CYP27A1 macrophages are maintained in RPMI 1640 medium containing 10% fetal bovine serum and 1% penicillin/streptomycin at 37°C, 5% CO 2 . Cells are incubated at 10 6 cells/ml in the presence of PMA for 4 days in order to induce differentiation into macrophages. apoE KD or CYP27A1 KD macrophages are labeled with 3 Hcholesterol (0.2 μCi/ml) for 24 h (37°C, 5% CO 2 ). The cells are washed two times with serum-free medium containing 0.2% BSA and then cultured overnight in medium. To measure the effect of adenosine receptor agonists/antagonists on cholesterol efflux, cells are incubated for 24 h with 50 μg/ml apolipoprotein A1 (apoA1) in the absence or presence of CGS21680 (1 μg/ml), ZM-241385 (1 μg/ml), or their combination and IFNγ. At the end of the incubation, cells are centrifuged (10,000 G for 5 min) to remove medium and then lysed. Aliquots (200 μl) from the medium to cells are counted separately using liquid scintillation counting [1] .
Statistics
Reported as the mean±SEM, differences between treatment groups were analyzed by using one-way ANOVA followed by unpaired Student's t test to evaluate levels of significance. p<0.05 was accepted as being statistically significant. All statistical analyses are performed with SigmaStat software v. 3.0 (SPSS, Inc., Chicago, IL, USA).
RESULTS
Lentiviral Constructs Reduce apoE and CYP27A1 mRNA in Human THP-1 Cells
We have previously shown that adenosine acting at A 2A receptors stimulates ABCA1-dependent cholesterol efflux but not ABCG1-dependent cholesterol efflux [1] . In order to further probe the mechanism by which adenosine receptor activation enhances cholesterol efflux from macrophages to diminish foam cell formation, we diminished expression of other molecules involved in reverse cholesterol transport. Using siRNA technology, we were able to reduce apoE mRNA expression (p<0.0001, apoE siRNA vs. scrambled siRNA, n=3) and apoE protein expression (Fig. 1) . We also reduced 27-hxdroxylase mRNA expression (p < 0.0001, CYP27A1 siRNA vs. scrambled siRNA, n=3) and CYP27A1 protein expression (p < 0.01, CYP27A1 siRNA vs. control n=3) in order to more accurately access adenosine receptor stimulation on reverse cholesterol transport (Fig. 2) . [3, 4] ). In contrast, neither IFNγ nor CGS21680 significantly affects expression of mRNA for apoE (Fig. 3) . Adenosine A 2A receptor activation stimulates cholesterol efflux from and diminishes foam cell formation by macrophages formed from THP-1 cells by a mechanism dependent on ABCA1 expression. To more fully understand how adenosine A 2A receptor stimulation promotes cholesterol efflux and inhibits foam cell formation, we determined whether the adenosine A 2A receptor agonist CGS-21680 (1 μM) inhibits foam cell formation in apoE KD cells. We found that the loss of apoE expression did not affect the capacity of CGS21680 to inhibit foam cell formation (Fig. 4) , a phenomenon completely reversed by the A 2A R antagonist ZM-41385. However, the adenosine A 2A receptor agonist CGS-21680 lost the capacity to diminish foam cell formation in CYP27A1 KD cells (Fig. 5) . This surprising observation is consistent with the hypothesis that adenosine receptor-mediated stimulation of CYP27A1 expression also plays a role in inhibiting foam cell formation by an apoE-independent mechanism.
Cholesterol Uptake Is Unaffected by Adenosine Receptor Activation in apoE KD and CYP27A1 Macrophages
Because cholesterol is actively taken up by macrophages during foam cell formation and requires the docking of HDL/apoA-I to receptors such as ABCA1 and ABCG1, we determined whether the A 2A receptor agonist CGS-21680 decreased foam cell formation by inhibiting cholesterol uptake. We found that the A 2A receptor agonist CGS-21680 did not diminish cholesterol uptake in either apoE or CYP27A1 KD cells (Fig. 6a, b) . These findings further suggest the hypothesis that CGS-21680 does not decrease foam cell formation by inhibiting cholesterol uptake but by enhancing cholesterol efflux in an ABCA1-and CYP27A1-dependent manner. 3 H-cholesterol efflux, p<0.0300 vs. control, n = 3) in IFNγ-treated apoE KD macrophages, but not in CYP27A1 KD cells (Fig. 7a, b) . This finding further corroborates the hypothesis that Fig. 3 . A 2A adenosine receptor agonist CGS-21680 has no effect on apoE mRNA expression. THP-1 cells (106/ml) in suspension were incubated for 3 h (37°C, 5% CO2) with or without IFNγ (500 U/ml), A 2A adenosine receptor agonist CGS-21680 (1 μM), and A 2A adenosine receptor antagonist ZM-241385 (1 μM). Total RNA was analyzed for apoE by real-time PCR and normalized to GAPDH. Gene expression levels were graphed as relative mRNA (percent of control). adenosine receptor activation increases cholesterol efflux by a CYP27A1-dependent mechanism, which is associated with diminished foam cell formation.
ABCA1 Protein Levels Are Unaffected in CYP27A1 KD Cells Treated with Adenosine Receptor Agonist CGS-21680
We have shown that ATP binding cassette transport protein ABCA1 is required for adenosine receptormediated cholesterol transport and that A 2A receptor stimulation decreases foam cell formation and increases expression of ABCA1 and CYP27A1 [13] . Previous reports indicate that oxysterols, potentially produced by CYP27A1, are critical for stimulation of ABCA1 expression [14] . To determine whether the effects of adenosine A 2A receptor-mediated promotion of cholesterol efflux and inhibition of foam cell formation result from the indirect increase in expression of ABCA1, we determined whether CGS21680 regulated ABCA1 expression in the absence of CYP27A1 expression. We found that in CYP27A1 KD cells, adenosine receptor agonist CGS-21680 did not lose its capacity to stimulate ABCA1 protein expression (p<0.0001, IFNγ CGS vs. control, n =4; Fig. 8 ). This finding suggests that adenosine receptor activation decreases foam cell formation and increases CYP27A1-and ABCA1-dependent cholesterol efflux through two independent mechanisms. 6 . A 2A adenosine receptor agonist CGS-21680 has no effect on cholesterol uptake in apoE KD or in 27-hyroxylase KD cells. apoE KD (a) or CYP27A1 KD (b) macrophages were incubated in Ham's 12 medium (37°C, 5% CO2) in the presence of AlexaFluor acLDL (acetyl-LDL; 5 μg/ml) with or without IFNγ (500 U/ml), and A 2A adenosine receptor agonist CGS-21690 (1 μM) for 3 h. Cells were washed five times with PBS, and fluorescence intensity was quantified (435/ 535 nm) in the Victor
DISCUSSION
Here, we report that adenosine A 2A receptor stimulation promotes cholesterol efflux and inhibits foam cell formation by a mechanism dependent on expression of CYP27A1. We have previously demonstrated that adenosine A 2A receptor stimulation promotes cholesterol efflux and inhibits foam cell formation by a mechanism dependent on ABCA1. It is likely that in vivo these mechanisms are complementary.
Both apoE and CYP27A1 play important roles in regulating cholesterol transport. In the case of apoE activation, chylomicrons and liver-derived very low-density liporproteins (VLDL) are primarily responsible for the transport of lipids from extrahepatic cells to the liver. Ultimately, these triglyceride-rich lipoproteins become hydrolyzed, leading to the formation of triglyceride-rich lipoprotein remnants [15] . Subsequently, hydrolyzed remnants become enriched with high-density lipoprotein (HDL)-derived apoE. apoE plays a critical role in facilitating the clearance of chylomicrons, remnant particles, and VLDL and is a major component of several classes of plasma lipoproteins [16] . apoE has been implicated in maintenance of overall plasma cholesterol homeostasis by facilitating the binding to LDL receptors on hepatic cells, stimulating cholesterol efflux from macrophages, preventing platelet aggregation, to inhibiting proliferation of Tlymphocytes and endothelial cells [10] .
The enzyme CYP27A1 belongs to a family of cytochrome P450 enzymes involved in regulating the formation of bile acids [8] . It plays a role in maintaining cholesterol homeostasis by catalyzing the conversion of cholesterol to oxysterols which activate ABCA1 transcription leading to increased cholesterol efflux [17] . It is CYP27A1 KD macrophages were incubated with IFNγ (500 U/ml), CGS-21680 (1 uM), or IFNγ (500 U/ml) and CGS-21680 (1 uM) for 24 h. Protein levels were quantified by calculating the average band intensity of 27-hyrdroxylase/band intensity B-actin. also important to note that dysregulation of CYP27A1 leads to accelerated atherosclerosis and has been implicated in the advanced atherosclerosis that occurs prematurely in patients with lipid storage disease [8] . Our aim was to see whether activating the adenosine A 2A receptor would lead to an increase in enhanced apoE or CYP27A1-dependent cholesterol efflux.
In a previous study, we focused on two ATP binding cassette transporter genes known to be involved in reverse cholesterol transport: ABCA1 and ABCG1 [1] . We tested whether activation of adenosine A 2A receptor had any influence on ABCA1 or ABCG1 expression or function. We found that adenosine A 2A receptor activation did in fact influence ABCA1 expression and ABCA1-dependent cholesterol efflux, but not ABCG1 expression or ABCG1-dependent cholesterol efflux. Because apolipoproteins and enzymes also regulate cholesterol homeostasis and transport from macrophages, we also determined whether adenosine A 2A receptor activation had any effect on apoE or CYP27A1 expression or function. We found that adenosine A 2A receptor activation had no effect on apoE mRNA levels. Also, in apoE KD cells, adenosine A 2A receptor agonist CGS-21680 was able to decrease foam cell formation as was the case in wild-type and ABCG1 KD macrophages as reported previously. However, CGS-21680 was not able to decrease foam cell formation in CYP27A1 KD cells. In apoE and CYP27A1 KD cells, adenosine A 2A receptor agonist CGS-21680 did not influence cholesterol uptake. In apoE KD cells, CGS-21690 increased cholesterol efflux but was not able to increase cholesterol efflux in CYP27A1 KD cells. The data reported from apoE KD to CYP27A1 KD cells corroborate the claim that adenosine A 2A receptor activation enhances cholesterol efflux by ABCA1-and CYP27A1-dependent mechanisms. Cholesterol transport proteins such as ABCG1 and apoE are not influenced by adenosine receptor signaling.
